Regulatory
Excellence:
Delivered
Specialist UK medicines Regulatory Affairs support
Fusion is an award winning UK Regulatory Affairs consultancy supporting pharmaceutical and biotech companies. We combine specialist expertise with curiosity, tenacity and genuine client partnership to help clients obtain, maintain and optimise UK marketing authorisations.
From regulatory strategy and submissions to lifecycle management and in-house support, we bring clarity, momentum and consistently high standards to complex regulatory work.
UK regulatory support across the medicines lifecycle
We provide strategic and practical regulatory support from early development and clinical trials through marketing authorisation, product launch and post-approval lifecycle management. Our team can manage a defined project, work alongside your internal regulatory function or provide ongoing regulatory support.
Regulatory strategy
Clear, evidence-led strategies covering UK and EU submission routes, MHRA engagement, Scientific Advice and pre-submission meetings.
Regulatory submissions
End-to-end support for CTAs, marketing authorisation applications, regulatory queries, variations and product information.
In-house regulatory support
Experienced UK regulatory professionals who integrate with your team for added capacity, senior input and continuity.
Entering the UK market
Practical support navigating MHRA requirements, UK marketing authorisations, launch readiness and MAH responsibilities.
A regulatory partner that brings clarity and progress
We combine detailed knowledge of UK medicines regulation with practical experience of how regulatory requirements are applied. Clients choose Fusion Pharma for clear thinking, well-structured documentation and a team that takes ownership, follows through and remains focused on progress.
Clear and dependable delivery
Defined responsibilities, realistic timelines, transparent risk management and documentation that stands up to scrutiny.
Flexible regulatory support
Choose defined project support, temporary integration with your internal team or ongoing managed delivery.
Genuine client partnership
Responsive, straightforward support from people who invest in understanding your objectives and work as an extension of your team.
Award winning consultancy
Fusion Pharma was a winner of the 2025 TOPRA Award for Regulatory Excellence in Communication and the 2025 Pharma Industry Awards UK Communications Award. These awards recognise the clear, collaborative and effective communication that underpins our regulatory work and client relationships.
Fusion Newsletter
Welcome Dilyana
We are delighted to welcome Dilyana to the Fusion Pharma team as our newest Regulatory Affairs Consultant....
National vs IRP – what are the pros & cons
Part of a successful regulatory strategy is to assess all available routes to licensing medicines and select...
ePIL updates in the UK and EU
ePIL plans are progressing in both the UK and the EU. The aim is to make medicines...
Ex-regulator tips for streamlining your dossier
I still vividly remember my days at the MHRA – reviewing countless dossiers, applications, and cover letters...
Testimonials
Talk to us about your UK regulatory project
Whether you need a regulatory strategy, support with a submission, additional team capacity or guidance on entering the UK market, we will help you establish the right approach and clear next steps.